Document is current
Any future updates will be listed below
-
Authors
Milatz, Florian https://orcid.org/0000-0002-0090-5534
Hansmann, Sandra
Klotsche, Jens
Niewerth, Martina
Kallinich, Tilmann
Dressler, Frank
Haas, Johannes-Peter
Berendes, Rainer
Horneff, Gerd
Hufnagel, Markus
Weller-Heinemann, Frank
Windschall, Daniel
Trauzeddel, Ralf
Klaas, Moritz
Girschick, Hermann
Oommen, Prasad T.
Foeldvari, Ivan
Cantez, Serdar Mustafa
Jansson, Annette F.
Hartmann, Matthias
Peitz-Kornbrust, Joachim
Minden, Kirsten
-
Funding
Funding for this research was provided by:
Deutsche Kinderrheuma-Stiftung
AbbVie Deutschland
Chugai Pharmaceutical
GlaxoSmithKline foundation
Novartis Pharma
Pfizer
Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
- License Information
-
More Information
Article History
Received: 13 December 2023
Accepted: 13 March 2024
First Online: 20 March 2024
Declarations
:
: This observational study was conducted following the principles of good clinical practice, the Declaration of Helsinki, and current ethical standards. The NPRD initiative obtains anonymized medical routine data and was approved by the ethics committee of the Charité – Universitätsmedizin Berlin (IRB approval number: EA1/044/07). Written informed consent was obtained from all participating parents or subjects themselves.
: Not applicable.
: The authors declare that they have no competing interests.
